Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.
about
Genome stability pathways in head and neck cancersIn vitro non-homologous DNA end joining assays--the 20th anniversary.Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities.Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model.Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitization.DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.Investigation of radiosensitivity gene signatures in cancer cell lines.New biological markers in the decision of treatment of head and neck cancer patients.The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma.Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa.Biologic activity of a dinuclear Pd(II)-spermine complex toward human breast cancer.
P2860
Q28391355-4D0A20A0-2375-4368-8DDA-F62EB219774FQ33980430-ADA73AC8-30B2-485B-90CB-3F8EC039C138Q34017782-9935BC68-2A6F-47F7-AFE4-79C3287A9A8BQ34162522-476F3115-DCE8-494A-8068-6781344EACC8Q34887304-5822F940-D009-47E1-837B-99D82DD40832Q34974246-15660D5C-113C-4851-8C1D-F7A05C27798FQ36557197-394C0A80-F6A7-4FF7-A879-4822225EC402Q37481225-9876ECA4-E3AE-4A91-ACD7-F8A01DDB7C1EQ37505655-12DEE480-5E3A-4188-8647-8E43122E22A9Q38225012-4735217C-E3E8-434C-8349-0EA16E078719Q38690281-85FB0DEA-2523-43D4-8D0B-F62895AFC7A8Q39159264-3630749F-FB77-496C-8BDB-D2BBD00682BDQ46609517-EA63238C-1ABB-4BD8-81BE-5CE30EA52539Q48521555-81ABF735-EF4D-458B-9BE1-C8A20F76102BQ54607960-66970C08-E728-4C34-B1CC-F823481E36A2
P2860
Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Ku70 predicts response and pri ...... advanced head and neck cancer.
@en
Ku70 predicts response and pri ...... advanced head and neck cancer.
@nl
type
label
Ku70 predicts response and pri ...... advanced head and neck cancer.
@en
Ku70 predicts response and pri ...... advanced head and neck cancer.
@nl
prefLabel
Ku70 predicts response and pri ...... advanced head and neck cancer.
@en
Ku70 predicts response and pri ...... advanced head and neck cancer.
@nl
P2093
P2860
P50
P356
P1476
Ku70 predicts response and pri ...... advanced head and neck cancer
@en
P2093
Agustí Barnadas
Antonio Lopez-Pousa
Francesc J Sancho
Maria Antonia Mangues
Maria Virtudes Céspedes
Matilde Parreño
Ramón Mangues
P2860
P304
P356
10.1002/IJC.23635
P577
2008-09-01T00:00:00Z